Balyasny Asset Management L.P.

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1218710 Chicago, IL

Back to AMRX Full portfolio

Position in AMRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,514,824

+$6,531,326 QoQ

Shares Held

434,132

+448.7% QoQ

Ownership

0.136%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#51

of 305 holders

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $126,095,704 across 18 Drug Manufacturers - Specialty & Generic names. AMRX ranks #7 (6.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LNTH	Lantheus Holdings, Inc.	277,821	$30,821,461
2	KNSA	Kiniksa Pharmaceuticals International, plc	309,682	$19,804,163
3	BIOA	BioAge Labs, Inc.	702,858	$17,227,049
4	AMLX	Amylyx Pharmaceuticals, Inc.	684,974	$12,302,133
5	TAK	Takeda Pharmaceutical Co Ltd	511,336	$8,196,716
6	HIMS	Hims & Hers Health, Inc.	218,958	$7,591,273
7	AMRX	Amneal Pharmaceuticals, Inc. This page	434,132	$7,514,824
8	ALKS	Alkermes plc.	142,366	$7,459,978

All Filings in AMRX

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,514,824	434,132	+448.7%	Shares	Sole	2026-08-14
2026-03-31	$983,498	79,123	-88.5%	Shares	Sole	2026-05-15
2025-12-31	$8,692,324	689,867	+6.8%	Shares	Sole	2026-02-17
2025-09-30	$6,468,321	646,186	+223.1%	Shares	Sole	2025-11-14
2025-06-30	$1,617,911	199,989	-72.2%	Shares	Sole	2025-08-14
2025-03-31	$6,025,890	719,080	+317.3%	Shares	Sole	2025-05-15
2024-12-31	$1,364,718	172,313	+482.3%	Shares	Sole	2025-02-14
2023-09-30	$124,886	29,594	+22.5%	Shares	Sole	2023-11-14
2020-03-31	$84,045	24,151	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.